Raw 7-OH vs Full-Spectrum Kratom Tablets: What '42 Alkaloids' Actually Means

Two product categories, one plant, and a very different answer to the same question: what’s actually in this?

Through early 2026, shoppers compared raw 7-OH products — isolates built around a single concentrated molecule — against whole-leaf formats. That comparison is now historical. The one that matters today is between what raw 7-OH products were and what full-spectrum kratom tablets are: the leaf’s entire naturally occurring alkaloid profile, verified on an accredited lab panel. This article walks that chemistry, publishes the citation-backed list behind the “42 alkaloids” on our labels, and shows real COA numbers from a production batch. Identification and measurement only — no claims about what any compound does.

What “Raw 7-OH” Products Were

“Raw 7-OH” described a format: loose, unflavored, high-concentration 7-hydroxymitragynine powder — and the tablets pressed from it. The defining trait was isolation: one alkaloid out of the leaf’s dozens, extracted, refined, and concentrated far beyond anything the plant produces. In leaf, 7-hydroxymitragynine is a trace constituent — typically around 2% or less of the alkaloid fraction (Takayama 2004; FDA). Raw 7-OH inverted that ratio: the trace constituent became essentially the whole jar. The full format breakdown is in Raw 7-OH, Explained, and how an isolated molecule compares chemically to its leaf-borne counterpart is covered in our natural-vs-synthetic chemistry explainer — we won’t duplicate either here.

That era closed. Under DEA’s proposed scheduling action for 7-OH (docket DEA-1570, proposing thresholds of >1mg per article or 0.05% dry weight — final rule still pending), concentrated 7-OH sales ended industry-wide in September 2026; Favor’d Alkz processed its final 7-OH sale on September 24, 2026. What replaced it is not a tweaked isolate. It’s the other end of the spectrum entirely.

What “Full-Spectrum” Actually Means

A full-spectrum kratom tablet contains the leaf’s complete naturally occurring alkaloid profile, in the proportions the plant made it. Where a raw 7-OH product was defined by what was removed, a full-spectrum product is defined by what was kept.

How many compounds is that? The peer-reviewed record is specific: Flores-Bocanegra et al. (2020) report at least 54 alkaloids isolated and identified from Mitragyna speciosa. Mitragynine dominates, followed by paynantheine, speciogynine, and speciociliatine, with a long tail of minor and trace alkaloids — heteroyohimbines, N(4)-oxides, nine distinct oxindoles — and naturally occurring 7-hydroxymitragynine in its native place as a trace constituent, around 2% or less of the alkaloid fraction.

Our tablet line is named for 42 of those alkaloids — the subset we can put a specific name, class, and literature citation against, compound by compound. The label is deliberately conservative: the published record documents more alkaloids than we claim, not fewer. Here is the entire list.

The 42 Alkaloids, With Citations

This list is compiled from peer-reviewed literature only: Takayama 2004 (Chem Pharm Bull 52:916–928), Flores-Bocanegra et al. 2020 (J Nat Prod 83:2165–2177), Manwill et al. 2022 (Planta Med 88:838–857), Hanapi et al. 2021 (Front Pharmacol 12:751656), Chakraborty et al. 2021 (ACS Chem Neurosci 12:2661–2678), Veeramohan et al. 2023 (PLoS One 18:e0283147), and Kanumuri et al. 2026 (Pharm Biol 64:902–920), with abundance cross-checks against Cinosi et al. 2015 (BioMed Res Int 2015:968786). The literature reports at least 54 alkaloids isolated from M. speciosa; the 42 below are the best-documented named structures — no isomers were invented to pad the count. Abundance tiers: Major = mitragynine-class (~66% of the crude alkaloid fraction in Thai-origin leaf; ~12% in Malaysian-origin leaf, per Takayama 2004); Minor = roughly 0.5–10% of the alkaloid fraction; Trace = below that, or detected only in specific chemotypes or leaf stages. Scope: chemistry and identification only.

Legend: ◆ = alkaloid quantified on our ISO/IEC 17025 lab panel (bolded rows).

Lab-panel note: our panel quantifies nine analytes. Eight appear in the table above (◆): mitragynine, 7-hydroxymitragynine, speciociliatine, paynantheine, speciogynine, corynantheidine, mitraphylline, and mitragynine pseudoindoxyl. The ninth, dihydro-7-hydroxymitragynine (MGM-15) ◆, is a mitragynine-derived transformation product quantified for product characterization; it is not counted among the 42 plant-identified alkaloids above, which keeps this list strictly literature-defensible.

Count note: the literature total is higher than 42 — Flores-Bocanegra et al. 2020 state at least 54 alkaloids have been isolated from M. speciosa, and Hanapi et al. 2021 cite roughly 45 identified. “42 alkaloids” is therefore a conservative, fully citable subset of the published record.

What Our Lab Actually Measures

No commercial lab panel quantifies 42 compounds — reference standards don’t exist for most trace alkaloids — so honest full-spectrum labeling means saying exactly what is measured. Our ISO/IEC 17025-accredited panel (BullsEye Testing) quantifies nine analytes per batch: mitragynine, 7-hydroxymitragynine, speciociliatine, paynantheine, speciogynine, corynantheidine, mitraphylline, mitragynine pseudoindoxyl, and MGM-15. The last three routinely report below detection limits in our products — which matters, because mitragynine pseudoindoxyl, MGM-15, and MGM-16 are named in DEA-1644 (in force, zero-threshold), and the panel verifies, batch by batch, that we sell none of them.

Here are the real numbers from the Blueberry tablet batch COA, per tablet:

The shape matches the literature: mitragynine dominant, the other majors in their expected minor band, and naturally occurring 7-OH at 1.721mg — about 0.56% of the measured alkaloid fraction, inside the leaf’s documented trace range. That is full-spectrum on paper: the leaf’s ratios, measured, not a single amplified number. Current certificates are published at /pages/lab-results.

How to Read a Full-Spectrum Tablet Label

With an isolate, the label number was 7-OH milligrams. With a full-spectrum tablet, the anchor number is milligrams of mitragynine per tablet — the dominant alkaloid is the honest basis for comparison. Current per-tablet figures from batch COAs:

• Grape — 128.5mg mitragynine per tablet
• Cherry — 156.0mg mitragynine per tablet
• Blueberry — 195.7mg mitragynine per tablet
• Passion Fruit — figures publish when its batch COA finalizes

Three checks on any full-spectrum label, ours included: the mitragynine figure traces to a lot-matched COA from a named, accredited lab; the COA quantifies multiple alkaloids, not one headline analyte; and the per-tablet total reconciles with the per-analyte lines, as the 307.008mg Blueberry total does above. A “full-spectrum” claim backed by a single-analyte COA is an isolate wearing a different label.

FAQ

Does kratom really have 42 alkaloids?

It has more. Peer-reviewed literature documents at least 54 alkaloids identified in Mitragyna speciosa (Flores-Bocanegra et al. 2020). The 42 in our table are the best-documented named structures — the citable subset our tablet line is named for. The label count is conservative by design.

What is full-spectrum kratom?

A full-spectrum kratom product contains the leaf’s complete naturally occurring alkaloid profile in the plant’s own proportions — mitragynine dominant, minor and trace alkaloids intact, including trace naturally occurring 7-hydroxymitragynine — rather than one alkaloid isolated and concentrated.

What happened to raw 7-OH products?

Sales of concentrated 7-OH products ended industry-wide in September 2026 under DEA’s proposed scheduling action (docket DEA-1570; final rule still pending). Favor’d Alkz completed its final 7-OH sale on September 24, 2026, and now carries full-spectrum tablets and capsules only.

How much mitragynine is in each tablet?

Per current batch COAs: Grape 128.5mg, Cherry 156.0mg, Blueberry 195.7mg of mitragynine per tablet; Passion Fruit figures publish when its batch COA finalizes. Certificates live at /pages/lab-results.

This article is for informational and chemical-identification purposes only. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Products are intended for adults 21 years of age or older. Check your state and local laws before purchasing.